No profile data available.
Humacyte, Inc. (HUMA) is a healthcare company in the targeted healthcare equipment industry, based in Durham, United States, with about 218 full-time employees.
It reported revenue of $2.04 million for fiscal year 2025, and net income of -$40.83 million. Its market capitalization was $243.45 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
, together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.
Humacyte reported $2.04 million in revenue for fiscal year 2025.
$243.45 million as of December 4, 2025.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include NeuroPace, Inc. (NPCE), ClearPoint Neuro, Inc. (CLPT), CapsoVision, Inc. (CV), Utah Medical Products, Inc. (UTMD).